E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions
Seyed Mohammad Hosseini(Tabriz University of Medical Sciences), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Isobel Okoye, Gholamreza Azizi(Jefferson Hospital for Neuroscience), Mitra Ghasemi Chaleshtari(Tabriz University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Siamak Sandoghchian Shotorbani(University of Tabriz), Hamed Mohammadi(Tehran University of Medical Sciences), Bita Hazhirkarzar(Johns Hopkins University), Javad Mohamadnejad(University of Tehran)
Cited by 70
Related Papers
MicroRNA-Containing T-Regulatory-Cell-Derived Exosomes Suppress Pathogenic T Helper 1 Cells
|Immunity|2014|596
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
|International Immunopharmacology|2022|384
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
|Frontiers in Immunology|2022|363
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
|Scandinavian Journal of Immunology|2020|339